DIA Share Price

Open 71.00 Change Price %
High 71.95 1 Day 0.25 0.35
Low 70.70 1 Week -0.05 -0.07
Close 71.60 1 Month 1.45 2.07
Volume 44119 1 Year 15.00 26.50
52 Week High 75.15
52 Week Low 49.98
DIA Important Levels
Resistance 2 72.76
Resistance 1 72.28
Pivot 71.42
Support 1 70.92
Support 2 70.44
BIT Italy Most Active Stocks
ISP 2.87 -1.03%
PMI 0.36 0.00%
PMI 0.36 0.00%
TIT 0.82 -1.20%
F 6.94 -2.12%
F 6.94 -2.12%
F 6.94 -2.12%
F 6.94 -2.12%
UCG 17.60 -0.85%
BNS 0.67 -2.90%
More..
BIT Italy Top Gainers Stocks
PGR 300.00 20.00%
PGR 300.00 20.00%
PGR 300.00 20.00%
PGR 300.00 20.00%
NR 2.05 7.89%
NR 2.05 7.89%
NR 2.05 7.89%
VRW 1.13 6.60%
VRW 1.13 6.60%
RM 0.53 6.00%
More..
BIT Italy Top Losers Stocks
RN 0.03 -25.00%
RN 0.03 -25.00%
ME 0.09 -10.00%
ME 0.09 -10.00%
EEMS 0.09 -10.00%
BMPS 15.08 -7.48%
ENV 3.30 -4.07%
ENV 3.30 -4.07%
ENV 3.30 -4.07%
ENV 3.30 -4.07%
More..

Diasorin (BIT: DIA)

DIA Technical Analysis 4
As on 22nd Aug 2017 DIA Share Price closed @ 71.60 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 61.90 & Buy for SHORT-TERM with Stoploss of 70.41 we also expect STOCK to react on Following IMPORTANT LEVELS.
DIA Target for August
1st Target up-side 78.61
2nd Target up-side 82.09
3rd Target up-side 85.56
1st Target down-side 68.69
2nd Target down-side 65.21
3rd Target down-side 61.74
DIA Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.diasorin.com
DIA Address
DIA
Via Crescentino
Saluggia, VC 13040
Italy
Phone: 39 01 614871
DIA Latest News
How Does DiaSorin SpA (BIT:DIA)'s MF Rank Stack Up?   Buckeye Business Review   - 21st Aug 17
Global Cell Control Market 2017- Beckman, DiaSorin SpA, BIOKIT ...   Invest Daily News: Market Research News by Market.Biz (press release)   - 18th Aug 17
Cell Control Market Professional Study by Expert 2017 to 2022   Medgadget (blog)   - 15th Aug 17
Indonesia IVD Market Analysis   PR Newswire (press release)   - 09th Aug 17
Will DIASORIN SRL ORD (OTCMKTS:DSRLF) Run Out of Steam Soon? Short Interest Is ...   Weekly Register   - 10th Jul 17
New measurement technique lowers estimated vitamin D recommended daily allowance   Science Daily   - 02nd Apr 17
Danaher Buys Molecular Diagnostics Firm Cepheid For $4 Billion   Med Device Online (press release)   - 07th Sep 16
DiaSorin SpA Completes Acquisition of the Focus Diagnostics' Molecular and ...   PR Newswire (press release)   - 14th May 16
DiaSorin To Acquire Focus Diagnostics' Molecular And Immunoassay Product ...   PR Newswire (press release)   - 30th Mar 16
DiaSorin SpA ADR   MarketWatch   - 15th Jun 12
Interactive Technical Analysis Chart Diasorin ( DIA BIT Italy )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Diasorin
DIA Business Profile
DiaSorin S.p.A. is engaged in the development, production, and commercialization of diagnostic tests that are designed for hospital and private testing laboratories for use in different clinical areas in the market of immunodiagnostics and molecular diagnostics. The company offers immunodiagnostics products for diagnosis of infectious diseases; immunoassays for the management of bone and calcium metabolic related diseases; endocrinology products for endocrine system diseases; such as diabetes, thyroid function, fertility, growth, adrenal function, and gastroenterology, bone and calcium metabolic related diseases, hypertension, and oncology; enzyme linked immunosorbent assays; and SPQ serum protein quantification assays. Its immunodiagnostics instruments include LIAISON XL, an automated chemiluminescence analyzer; LIAISON analyzer; ETI Max 3000, an automated microtiter plate analyzer; EVOlyzer 2-150/8 with disposable tips; and ELISA washers and readers. The company also offers molecular diagnostic products, including systems, software, kits, reagents, and consumables, such as Bullet Pro to perform extractions from different biological samples as required in big laboratories; LIAISON IXT to extract the nucleic acid from different biological samples and it is used in combination with LIAISON IAM amplification system; and LIAISON IAM to diagnose and monitor various infectious diseases and Onco-hematology parameters. In addition, it provides Middleware DiaLink 3000, a middleware solution. The company sells its products directly, as well as through an international network of independent distributors in Europe, Africa, Central America, South America, the Asia Pacific, and North America. DiaSorin S.p.A. was founded in 1968 and is headquartered in Saluggia, Italy.